Efficacy of rituximab monotherapy for an elderly hemodialysis patient with primary cardiac lymphoma

Internal Medicine

Volumn 49, Issue 19, 2010, Pages 2163-2166

  Morita, Yasuyoshi ^a   Matsuda, Mitsuhiro ^b   Yamaguchi, Terufumi ^a   Sakaguchi, Mika ^a   Rai, Shinya ^a   Kanai, Yoshitaka ^a   Hirase, Chikara ^a   Kawanishi, Kazunobu ^a   Miyatake, Junichi ^a   Shimada, Takahiro ^a   Tatsumi, Yoichi ^a   Ashida, Takashi ^a   Maeda, Yasuhiro ^a   Kanamaru, Akihisa ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b PL General Hospital   (Japan)

Author keywords

Chronic renal failure; Primary cardiac lymphoma; Rituximab monotherapy; Serum rituximab level

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; RITUXIMAB;

AGED; ARTICLE; B CELL LYMPHOMA; CASE REPORT; CHRONIC KIDNEY FAILURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFICACY; GENE REARRANGEMENT; HEMODIALYSIS; HUMAN; LARGE CELL LYMPHOMA; LYMPHOID CELL; MAINTENANCE THERAPY; MALE; MONOTHERAPY; MULTIPLE CYCLE TREATMENT; NONHODGKIN LYMPHOMA; PERICARDIAL EFFUSION; PRIMARY CARDIAC LYMPHOMA; TRANSTHORACIC ECHOCARDIOGRAPHY;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HEART NEOPLASMS; HUMANS; LYMPHOMA, B-CELL; MALE; PERICARDIAL EFFUSION; RENAL DIALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77958085931     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.4018     Document Type: Article

References (15)

1. Burke A, Virmani R. Tumors of the heart and great vessels. Series III. In: Atlas of Tumor Pathology. Fascicle 16. Rosai J, Sobin LH, Eds. Armed Forces Institute of Pathology, Washington, DC, 1996: 171-179.
2. McAllister HA Jr, Fenoglio JJ Jr. Tumors of the cardiovascular system. Series II. In: Atlas of Tumor Pathology. Fascicle 15. Armed Forces Institute of Pathology, Washington, DC, 1979: 99-100.
3. Chim CS, Chan AC, Kwong YL, Liang R. Primary cardiac lymphoma. Am J Hematol 54: 79-83, 1997.
4. Hainsworth JD, Litchy S, Burris HA 3rd, et al. Rituxmab as firstline and maintenance therapy for patients with indolent non- Hodgkin's lymphoma. J Clin Oncol 20: 4261-4267, 2002.
5. Colombat P, Salles G, Brousse N, et al. Rituximab (anti-CD20 monoclonal antibody) as single first-line therapy for patients with follicular lymphoma with a low tumor burden: clinical and molecular evaluation. Blood 97: 101-106, 2000.
6. Davis TS. Intravascular lymphoma presenting with cauda equina syndrome: treated with CHOP and rituxan. Leuk Lymphoma 44: 887-888, 2003.
7. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee Hodgkin's disease staging classification. Cancer Res 31: 1860-1861, 1971.
8. Jillella AP, Danier PM, Kallab AM, Ustun C. Treatment of a patient with end-stage renal disease with rituximab: Pharmacokinetic evaluation suggests rituximab is not eliminated by hemodialysis. Am J Hematol 71: 219-222, 2002.
9. Iacona I, Lazzarino M, Avanzini MA, et al. Rituximab (IDECC2B8): validation of a sensitive enzyme-linked immunoassay applied to clinical pharmacokinetic study. Ther Drug Monit 22: 295-301, 2000.
10. Ceresoli GL, Ferreri AJ, Bucci E, Ripa C, Ponzoni M, Villa E. Primary cardiac lymphoma in immunocompetent patients: diagnostic and therapeutic management. Cancer 80: 1497-1506, 1997.
11. Chalabreysse L, Berger F, Lorie R, Devouassoux G, Cordier JF, Thivolet-Bejui F. Primary cardiac lymphoma in immunocompetent patients: a report of three cases and review of literature. Virchows Arch 441: 456-461, 2002.
12. Nonami A, Takenaka K, Kamezaki K, et al. Successful treatment of primary cardiac lymphoma by rituximab-CHOP and high-dose chemotherapy with autologous peripheral blood stem cell transplantation. Int J Hematol 85: 264-266, 2007.
13. Nagamine K, Noda H. Two cases of primary cardiac lymphoma presenting with pericardial effusion and cardiac tamponade. Jpn Circ J 54: 1158-1164, 1990.
14. Rolla G, Bertero MT, Pastena G, et al. Primary lymphoma of the heart: a case report and review of literature. Leuk Res 26: 117-120, 2002.
15. Nakagawa Y, Ikeda U, Hirose M, et al. Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (Rituximab). Circ J 68: 172-173, 2004.